Evidence map›Paper›PMID 37200530›Full record

Observational studyRevista medica del Instituto Mexicano del Seguro Social2023

[Ethiology, risk factors and Whole blood viscosity index in thromboembolic venous disease].

Miguel Alejandro García-Gómez, Joaquín García-Pérez, Maria Fernanda Colorado-Cruz, Cinthya Paola López-Burgos, Berenice López-Zamora, Katia Melina León-Pérez, Héctor Antonio Solano-Cruz, María Del Pilar Cruz-Domínguez, Olga Lidia Vera-Lastra, Gabriela Medina-García

Open access · greenAbstract readEnglish AbstractObservational Study
In one paragraph

Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Miguel Alejandro García-GómezInstituto Mexicano del Seguro Social, Hospital de Especialidades "Dr. Antonio Fraga Mouret" Centro Médico Nacional La Raza, Departamento de Medicina Interna. Ciudad de México, México.ORCID 0000-0003-0440-0717
Joaquín García-PérezInstituto Mexicano del Seguro Social, Hospital de Especialidades "Dr. Antonio Fraga Mouret" Centro Médico Nacional La Raza, Departamento de Medicina Interna. Ciudad de México, México.ORCID 0000-0002-7724-501X
Maria Fernanda Colorado-CruzUniversidad Veracruzana, Campus Veracruz, Facultad de Medicina. Veracruz, Veracruz, México.ORCID 0000-0001-9942-138X
Cinthya Paola López-BurgosUniversidad Juárez Autónoma de Tabasco, Facultad de Medicina. Villahermosa, Tabasco, México.ORCID 0000-0002-0308-2975
Berenice López-ZamoraUniversidad Juárez Autónoma de Tabasco, Facultad de Medicina. Villahermosa, Tabasco, México.ORCID 0000-0003-1917-1240
Katia Melina León-PérezBenemérita Universidad Autónoma de Puebla, Facultad de Medicina. Puebla, Puebla, México.ORCID 0000-0003-2810-1949
Héctor Antonio Solano-CruzUniversidad Veracruzana, Campus Veracruz, Facultad de Medicina. Veracruz, Veracruz, México.ORCID 0000-0001-6492-8324
María Del Pilar Cruz-DomínguezInstituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Dirección de Educación e Investigación en Salud. Ciudad de México, México.ORCID 0000-0002-7118-9395
Olga Lidia Vera-LastraInstituto Mexicano del Seguro Social, Hospital de Especialidades "Dr. Antonio Fraga Mouret" Centro Médico Nacional La Raza, Departamento de Medicina Interna. Ciudad de México, México.ORCID 0000-0002-8729-9775
Gabriela Medina-GarcíaInstituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Unidad de Investigación en Medicina Traslacional en enfermedades hemato-oncológicas. Ciudad de México, México.ORCID 0000-0002-5891-8653
Universidad Veracruzana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Backround: Venous thromboembolic disease (VTED) is a frequent cause of hospitalization and mortality. Whole blood viscosity (WBV) participates in the pathogenesis of thrombosis. Objective: To identify the most frequent etiologies and their association with WBV index (WBVI) in hospitalized patients with VTED. Material and methods: Observational, cross-sectional, retrospective, analytical study, Group 1: cases (patients diagnosed with VTED) and Group 2: controls without thrombosis. Risk factors for VTED were described and WBVI was calculated from total proteins and hematocrit. Descriptive and inferential statistics were used with Chi-squared test, Fisher's exact test, Mann Whitney U test, bivariate and multivariate logistic regression analysis. Results: We included 146 patients and 148 controls, age 46.3 ±17.7 vs. 58 ± 18.2 years, of both sexes (female, 65.1%). The most frequent etiology was neoplastic (23.3%), followed by diseases with cardiovascular risk (17.8%). Independent risk factors for VTED were age, chronic kidney disease, presence of liver disease or solid neoplasia. WBVI was similar in patients with VTED as in those without thrombosis. We found an association of the presence of deep vein thrombosis and diseases with cardiovascular risk (p = 0.040). Conclusions: The presence of chronic kidney disease, liver disease, and solid neoplasia are independent risk factors for VTED. The WBVI is a simple and rapid diagnostic tool in the evaluation of patients with VTED.

Indexed as

NeoplasmsPulmonary EmbolismThromboembolismVenous ThrombosisAdultBlood ViscosityCross-Sectional StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsAutoimmune DiseasesBlood ViscosityPulmonary EmbolismVenous Thrombosis

Identifiers

PMID37200530
PMCPMC10399765
OpenAlexW4377093211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.